Primary patency rate of native AV fistula: Long term follow up

International Journal of Clinical and Experimental Medicine

Volumn 5, Issue 2, 2012, Pages 173-178

  Kazemzadeh, G H ^a   Modaghegh, M H S ^a   Ravari, H ^a   Daliri, M ^a   Hoseini, L ^b   Nateghi, M ^c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MUMS ^*  (Iran)

^c General Practitioner   (Iran)

Author keywords

Arteriovenous fistula; Dialysis; End stage renal disease; Patency; Primary failure

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTERIOVENOUS FISTULA; ARTICLE; ATHEROSCLEROSIS; CHILD; DEMOGRAPHY; DIABETES MELLITUS; DIALYSIS; FEMALE; FOLLOW UP; GENDER; GLOMERULONEPHRITIS; HUMAN; HYPERTENSION; KIDNEY POLYCYSTIC DISEASE; LONG TERM CARE; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PYELONEPHRITIS; SCHOOL CHILD; SURVIVAL; URINARY TRACT INFECTION; VASCULAR PATENCY;

EID: 84859949188     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. US Renal Data Systems. USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 2007.
2. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, van Lente F, Levey AS. Prevalence of Chronic Kidney Disease in the United States. JAMA 2007; 298: 2038-2047.
3. Konner K, Hulbert-Shearon TE, Roys EC and Port FK. Tailoring the initial vascular access for dialysis patients. Kidney Int 2002; 62: 329-338.
4. Brescia MJ, Cimino JE, Appel K, Hurwich BJ. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 1966; 275: 1089-1092.
5. Ravani P, Spergel LM, Asif A, Roy-Chaudhury P, Besarab A. Clinical Epidemiology of arterioven-ous fistula in 2007. J Nephrol 2007; 20: 141-149. C Surg 1999; 30: 727-733.
6. Juan A, Armadans L and Eugenio F. The function of permanent vascular access. Nephrol Dial Transplant 2000; 15: 402-408.
7. Rutherford RB. Vascular Surgery. 6th ed. Philadelphia, Pennsylvania. ELSEVIER SAUNDERS. 2005 Monroy-Cuadros M, Yilmaz S, Salazar-Bañuelos A, Doig Marko Malovrh. Strategy for the Maximal Use of Native Arteriovenous Fistu-lae for Hemodialysis. The Scientific World Journal 2006; 6: 808-881
8. Irish A, Dogra G, Mori T, Beller E, Heritier S, Hawley C, Kerr P, Robertson A, Rosman J, Paul-Brent PA, Starfield M, Polkinghorne K, Cass A. Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access outcomes in renal Disease (FAVOURED) study. BMC nephrol 2009; 10: 1.
9. Rooijens PP, Tordoir JH, Stijnen T, Burgmans JP, Smet de AA, Yo TI. Radiocephalic wrist arte-riovenous fistula for hemodialysis: Meta-analysis indicates a high primary failure rate. Eur J Vasc Endovasc Surg 2004; 28: 583-589.
10. Kalman PG, Pope M, Bhola C, Richardson R, Sniderman KW. A practical approach to vascular access for hemodialysis and predictors of success. J Vasc Surg 1999; 30: 727-733.
11. Diehm N, van den Berg JC, Schnyder V, Bühler J, Willenberg T, Widmer M, Mohaupt MG, Baumgartner I. Determinants of haemodialysis access survival. Vasa 2010; 39: 133-139.
12. Huijbregts HJ, Bots ML, Wittens CH, Schrama YC, Moll FL, Blankestijn PJ; CIMINO study group. Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative. Clin J Am Soc Nephrol 2008; 3: 714-719.
13. Wang W, Murphy B, Yilmaz S, Tonelli M, Macrae J, Manns BJ. Comorbidities do not influence primary fistula success in incident hemodialysis patients: A prospective study. Clin J Am Soc Nephrol 2008; 3: 78-84.
14. Nguyen TH, Bui TD, Gordon IL, Wilson SE. Functional patency of autogenous AV fistulas for hemodialysis. J Vasc Access 2007; 8: 275-280.
15. Bhalodia R, Allon M, Hawxby AM, Maya ID. Comparison of Radiocephalic Fistulas Placed in the Proximal Forearm and in the Wrist. Semin Dial 2011; 24: 355-357.
16. Saran R, Elder SJ, Goodkin DA, Akiba T, Ethier J, Rayner HC, Saito A, Young EW, Gillespie BW, Merion RM, Pisoni RL. Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study. Ann Surg 2008; 247: 885-891.
17. Jalal DI, Chonchol M, Targher G. Disorders of hemostasis associated with chronic kidney disease. Semin Thromb Hemost 2010; 36: 34-40.
18. Saran R, Elder SJ, Goodkin DA, Akiba T, Ethier J, Rayner HC, Saito A, Young EW, Gillespie BW, Merion RM, Pisoni RL. Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study. Ann Surg 2008; 247: 885-891.
19. Jalal DI, Chonchol M, Targher G. Disorders of hemostasis associated with chronic kidney disease. Semin Thromb Hemost 2010; 36: 34-40.
20. Rios DR, Carvalho MG, Lwaleed BA, Simões e Silva AC, Borges KB, Dusse LM. Hemostatic changes in patients with end stage renal disease undergoing hemodialysis. Clin Chim Acta 2010; 411: 135-139.
21. Małyszko J, Małyszko JS, Myliwiec M. Endothe-lial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis. Kidney Blood Press Res 2004; 27: 71-77.
22. Matsuo T, Koide M, Kario K, Suzuki S, Matsuo M. Extrinsic coagulation factors and tissue factor pathway inhibitor in end-stage chronic renal failure. Haemostasis 1997; 27: 163-167.
23. Segarra A, Chacón P, Martinez-Eyarre C, Arge-laguer X, Vila J, Ruiz P, Fort J, Bartolomé J, Camps J, Moliner E, Pelegrí A, Marco F, Olmos A, Piera L. Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: Biochemical correlations and role as independent predictors of coronary artery stenosis. J Am Soc Nephro 2001; 12: 1255-1263.
24. Takagi M, Wada H, Mukai K, Minamikawa K, Wakita Y, Deguchi K, Junji N, Hayashi T, Suzuki K, Shiku H. Increased activated protein C: protein C inhibitor complex and decreased protein C inhibitor levels in patients with chronic renal failure on maintenance hemodialysis. Clin Appl Thromb Hemost 1999; 5: 113-116.